North America Cellular Health Screening Market Size & Outlook

The cellular health screening market in North America is expected to reach a projected revenue of US$ 3,377.9 million by 2033. A compound annual growth rate of 8.9% is expected of North America cellular health screening market from 2025 to 2033.
Revenue, 2024 (US$M)
$1,567.8
Forecast, 2033 (US$M)
$3,377.9
CAGR, 2025 - 2033
8.9%
Report Coverage
North America

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America cellular health screening market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America cellular health screening market highlights

  • The North America cellular health screening market generated a revenue of USD 1,567.8 million in 2024.
  • The market is expected to grow at a CAGR of 8.9% from 2025 to 2033.
  • In terms of segment, single test panels was the largest revenue generating test type in 2024.
  • Multi-test Panels is the most lucrative test type segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2025 to 2033.


North America data book summary

Market revenue in 2024USD 1,567.8 million
Market revenue in 2033USD 3,377.9 million
Growth rate8.9% (CAGR from 2025 to 2033)
Largest segmentSingle test panels
Fastest growing segmentMulti-test Panels
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationSingle Test Panels, Multi-test Panels
Key market players worldwideCytek Biosciences Inc, Quest Diagnostics Inc, Labcorp Holdings Inc, OPKO Health Inc, Applied DNA Sciences Inc


Other key industry trends

  • In terms of revenue, North America region accounted for 47.6% of the global cellular health screening market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,333.7 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cellular Health Screening Market Scope

Cellular health screening market segmentation & scope
Telomere Tests
Oxidative Stress Tests
Inflammation Tests
Heavy Metals Tests
Multi-test Panels
Blood
Saliva
Serum
Urine
Home
Offices
Hospitals
Diagnostic Labs

Cellular Health Screening Market Companies

Name Profile # Employees HQ Website
Cytek Biosciences Inc View profile 637 47215 Lakeview Boulevard, Fremont, CA, United States, 94538 https://www.cytekbio.com
OPKO Health Inc View profile 3930 4400 Biscayne Boulevard, Miami, FL, United States, 33137 https://www.opko.com
Applied DNA Sciences Inc View profile 55 50 Health Sciences Drive, Stony Brook, New York, NY, United States, 11790 https://www.adnas.com
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Quest Diagnostics Inc View profile 48000 500 Plaza Drive, Secaucus, NJ, United States, 07094 https://www.questdiagnostics.com

North America cellular health screening market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cellular health screening market will help companies and investors design strategic landscapes.


Single test panels was the largest segment with a revenue share of 84.99% in 2024. Horizon Databook has segmented the North America cellular health screening market based on single test panels, multi-test panels covering the revenue growth of each sub-segment from 2021 to 2033.


North America accounted for the largest market share in 2020 and is expected to maintain its position during the forecast period. Increase in the importance of Healthy Life Expectancy (HALE), government focus on preventive healthcare, and rise in the burden of chronic diseases are some of the key factors expected to boost the market in the region. 

The U.S. accounted for the leading share in North America. Key factors contributing to its dominance include the local presence of major market players, easy availability of telomere tests & oxidative stress tests, high adoption of test from home, and increasing awareness about rare diseases. 

Canada is anticipated to exhibit the fastest growth rate in North America over the forecast period, owing to increasing healthcare expenditure and government initiatives to help spread awareness about cellular assessment.

Reasons to subscribe to North America cellular health screening market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America cellular health screening market databook

  • Our clientele includes a mix of cellular health screening market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America cellular health screening market , including forecasts for subscribers. This continent databook contains high-level insights into North America cellular health screening market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America cellular health screening market size, by country, 2021-2033 (US$M)

North America Cellular Health Screening Market Outlook Share, 2024 & 2033 (US$M)

North America cellular health screening market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online